Tissue Diagnostics Market to be Worth $8.52 Billion by 2029
Tissue Diagnostics Market - 2029 Page 1 of 5© Meticulous Research| sales@meticulousresearch.com
Meticulous Research® a leading global market research company, published a research report titled, ‘Tissue Diagnostics Market by Product Type (Antibodies, Kits, Reagents, Instruments [Slide Stainer, Scanner]), Technology (Digital Pathology, IHC, ISH, H&E Staining), Cancer Type (Breast, NSCLC,Colorectal, Prostate), End user -Global Forecast to 2029’. According to this latest publication from Meticulous Research, the global tissue diagnostics market is projected to reach $8.52 billion by 2029, at a CAGR of 7.4%. The rising prevalence of cancerglobally,theavailabilityofbiomarkersandresearchonbiomarkers,recommendations for cancer screening, the growing number of clinical trials for oncology drugs, and the availability of tissue based companion diagnostics are the factors driving the growth of this market.
Download Free PDF Sample Copy of the Report (with COVID 19Impact Analysis): https://www.meticulousresearch.com/download sample report/cp_id=4971 ScopeoftheReport: TissueDiagnosticsMarket,byProductType • Consumables o Antibodies o Kits
Tissue Diagnostics Market - 2029 Page 2 of 5© Meticulous Research| sales@meticulousresearch.com o Reagents • Instruments o Slide Staining Systems o Slide Scanners o Tissue Processors o OtherInstruments Note: Other instruments include microarraysand embedding systems. TissueDiagnosticsMarket,byTechnology • Immunohistochemistry (IHC) • In situ Hybridization (ISH) • Digital Pathology • H&E Slide Staining • OtherTechnologies Note: Other technologies include molecular, immunofluorescence, and special staining TissueDiagnosticsMarket,byApplication • Breast Cancer • Lung Cancer • Colorectaland Gastrointestinal Cancer • Prostate Cancer • Lymphatic Cancer • Other Applications Note: Other applications include cervical cancer, melanoma, lip, oralcavity cancer TissueDiagnosticsMarket,byEndUser • Hospitals and Reference Laboratories • Research Institutes • Pharmaceutical Companies • Contract ResearchOrganization TissueDiagnosticsMarket,byGeography • North America
Based on technology, the tissue diagnostics market is segmented into immunohistochemistry, in situ hybridization, digital pathology, H&E staining, and other technologies. In 2022, the immunohistochemistry segment is expected to account for the
The global tissue diagnostics market is segmented by Product Type (Consumables [Antibodies, Kits, Reagents], Instruments [Slide Staining Systems, Slide Scanners, Tissue Processing Systems, Other Instruments {Microarray, Embedding System]), Technology (Immunohistochemistry, In situ Hybridization, Digital Pathology, H&E Slide Staining, Other Technologies, Application (Breast Cancer, Lung Cancer, Colorectal and Gastrointestinal Cancer, Prostate Cancer, Lymphatic Cancer, Other Applications), End User (Hospitals and Reference Laboratories, Research Institutes, Pharmaceutical Companies, and Contract Research Organization). The study also evaluates industry competitors and analyzes their market sharesat the globaland regional levels.
Basedonproduct, in 2022, the consumables segment is expected to account for the largest share of the market. The extensive and recurring requirement of consumables and technologicaladvances indeveloping novelreagents contributeto the large marketshare of this segment.
Tissue Diagnostics Market - 2029 Page 3 of 5© Meticulous Research| sales@meticulousresearch.com o U.S. o Canada • Europe o Germany o U.K. o France o Italy o Spain o Rest of Europe (RoE) • Asia Pacific (APAC) o China o Japan o India o Rest of APAC (RoAPAC) • Latin America • Middle East & Africa
Togainmoreinsightsintothemarket
Tissuehttps://www.meticulousresearch.com/product/tissuewithadetailedtableofcontentandfigures,clickhere:diagnosticsmarket4971DiagnosticsMarket:FutureOutlook
Tissue Diagnostics Market - 2029 Page 4 of 5© Meticulous Research| sales@meticulousresearch.com
KeyquestionsansweredinthereportWhich are the high growth market segments in terms of product type, technology, application, end user, and regions/countries? What was the historicalmarket for tissuediagnosticsacross the globe?
largest share of the global tissue diagnostics market. Developments in in vitro diagnostics andtheupsurgeinpoint of carediagnosticsarethefactorscontributingtothegrowthofthis segment. RequestSampleReport: https://www.meticulousresearch.com/request sample
•
The key players operating in the global tissue diagnostics market are F. Hoffmann La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Abbott Laboratories (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Sigma Aldrich Co. LLC) (Germany), Sakura Finetek Japan Co., Ltd. (Japan), Abcam plc (U.K.), Becton, Dickinson, and Company (U.S.), QIAGEN N.V. (Netherlands), Cell Signaling Technology, Inc. (U.S.), Bio Genex Laboratories, Inc. (U.S.), BioSB, INC (U.S.), 3DHISTECH Ltd. (Hungary), and HOLOGIC, INC. (U.S.)
•
• What are the market forecasts and estimatesfor the period 2022–2029?
Based on end user,in 2022, the hospital and reference laboratories segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the high inflow of patients and tests due to the increasing prevalence of cancer. This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, and Rest of Asia Pacific), Latin America, and the Middle East& Africa. In2022,North America isexpected toaccountfor the largestshare ofthe tissuediagnosticsmarket. Thelargemarketshareofthisregionalmarketisdrivenbythehigh cancer prevalence, easy accessibility to advanced technologies, and the presence of public programs for cancermanagement.
• What are the major drivers, restraints, challenges, opportunities, and trends in the global tissue diagnostics market?
• Who are the major players in the global tissue diagnostics market?
Basedreport/cp_id=4971onapplication, the tissue diagnostics market is segmented into breast cancer, lung cancer, colorectal and gastrointestinal cancer, prostate cancer, lymphatic cancer, and other applications. In 2022, the breast cancer segment is expected to account for the largest share of the global tissue diagnostics market. The growth of this segment is attributed to the high prevalence of breast cancer and the presence of several research and screening programs for combating breast cancer.
781 8004 Connect
ContactSales
Tissue Diagnostics Market - 2029 Page 5 of 5© Meticulous Research| sales@meticulousresearch.com • How is the competitivelandscape,and whoare themarketleadersinthe global tissue diagnosticsmarket? • What are the recentdevelopments in the tissue diagnostics market? • Whatarethedifferentstrategiesadoptedbythemajorplayersinthetissuediagnostics market? • What are the geographical trends and high growth regions/countries? YoucanBuyReportfromHere:https://www.meticulousresearch.com/Checkout/27604669
ContactUs: sales@meticulousresearch.com +1 646 with us on LinkedIn https://www.linkedin.com/company/meticulous
Meticulous Research® Email
research